KALA - KALA BIO, Inc.
0.2939
0.033 11.364%
Share volume: 1,150,828
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$0.26
0.03
0.13%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-06-2024 | 11-12-2024 | 05-14-2025 | 08-08-2025 | 11-19-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | |||
| Operating expenses | 11.773 M | 9.634 M | 9.568 M | 10.648 M | 10.875 M | 10.661 M | |
| Selling general and admin | 5.422 M | 4.317 M | 4.400 M | 4.593 M | 4.643 M | 4.534 M | |
| Research and development | 6.351 M | 5.317 M | 5.168 M | 6.055 M | 6.232 M | 6.127 M | |
| Total expenses | 11.931 M | 9.605 M | 9.988 M | 10.669 M | 11.028 M | 7.239 M | |
| -19.50% | 3.99% | 6.82% | 3.36% | -34.36% | |||
| Operating income | -11.931 M | -9.605 M | -9.988 M | -10.669 M | -11.028 M | -7.239 M | |
| Ebit | -10.856 M | -8.625 M | -8.042 M | -8.319 M | -10.481 M | -6.871 M | |
| Pretax income | -11.807 M | -9.579 M | -8.950 M | -8.947 M | -11.155 M | -7.564 M | |
| -18.87% | -6.57% | -0.03% | 24.68% | -32.19% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -11.807 M | -9.579 M | -8.950 M | -8.947 M | -11.155 M | -7.564 M | |
| 18.87% | 6.57% | 0.03% | -24.68% | 32.19% |